|Articles|July 1, 2003

New guidelines for preventing heart disease

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Marisol Betensky, MD, on adapting pediatric VTE risk assessment | Image Credit: profiles.hopkinsmedicine.org.

Marisol Betensky, MD, on adapting pediatric VTE risk assessment

ByMarisol Betensky, MD

April 21st 2026

Marisol Betensky, MD, explains flexible pediatric VTE prophylaxis | Image Credit: profiles.hopkinsmedicine.org.

Marisol Betensky, MD, explains flexible pediatric VTE prophylaxis

ByMarisol Betensky, MD

April 20th 2026

Danielle Van Damme, DNP, CPNP-AC

A review of IDSA's 2024 complicated intra-abdominal infection clinical practice guideline

ByJoshua Fitch, Senior Editor , Danielle Van Damme, DNP, CPNP-AC

March 18th 2025

Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP

2025 immunization update: addressing vaccine hesitancy and catch-up vaccinations

ByJoshua Fitch, Senior Editor

March 11th 2025

AAP, AHA updates guidance for resuscitation following drowning | Image Credit: © Aleksandra Konoplya - © Aleksandra Konoplya - stock.adobe.com.

AAP, AHA update guidance for resuscitation following drowning

ByJoshua Fitch, Senior Editor

November 12th 2024

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

Teen sports supplements: What to recommend, use with caution, and avoid

Tezepelumab meets co-primary and secondary endpoints in phase 3 eosinophilic esophagitis trial

FAQ: What's new in COVID-19, RSV, and flu guidance?

How Breast Milk Shapes Gut Microbiome Signaling and Immunity

FDA approves apitegromab-mstn as first muscle-targeted therapy for spinal muscular atrophy